Ruslan Novo Pharmaceutical Private Limited

Ruslan Novo Pharmaceutical Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51909MH2017PTC301377 Incorporated 01 November 2017 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma Startup India
Revenue · FY 2025
₹38.74 Lakh
▲ 3% YoY
Net profit · FY 2025
₹39,346
Net margin 1%
EBITDA · FY 2025
₹61,574
EBITDA margin 1.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Open charges
₹7.5 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings

About Ruslan Novo Pharmaceutical Private Limited

Data last updated:

Ruslan Novo Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 November 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC301377. Its GSTIN is 23AAICR6000L1ZI (Madhya Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Harshika Dubey and Amit Kumar Joshi.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹38.74 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹39,346 (net margin 1%) and EBITDA of ₹61,574 (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 4% over five years.

As per MCA filings, the company has open charges of ₹7.5 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ruslannovo.com.

Company details

CIN U51909MH2017PTC301377
Registration Number 301377
Incorporation Date 01 November 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup

Recognitions & Rankings of Ruslan Novo Pharmaceutical

Startup India Government of India

Contact details

Ruslan Novo Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its website is ruslannovo.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Office No. 119 1st Floor Mastermind – V Royal Palms Aarey Milk Co, Lony, Mumbai, Maharashtra, India – 400065
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Ruslan Novo Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Ruslan Novo Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ruslan Novo Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Ruslan Novo Pharmaceutical Private Limited, buy the company report.

Financials of Ruslan Novo Pharmaceutical Private Limited

FY 2024 filings available

Ruslan Novo Pharmaceutical Private Limited reported revenue of ₹38.74 Lakh (up 3% YoY) for FY 2025.

Revenue · FY 2025
₹38.74 Lakh ▲ 3%
Net profit · FY 2025
₹39,346 margin 1%
EBITDA · FY 2025
₹61,574 margin 1.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 18%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 23%
5 years · compounded
▼ 13%

Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 3% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹61,574
Profit Before Tax
Tax Expense
Net Profit (PAT)₹39,346
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.6%
Net Profit Margin1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ruslan Novo Pharmaceutical Private Limited, buy the company report.

Board of directors of Ruslan Novo Pharmaceutical Private Limited

Ruslan Novo Pharmaceutical has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Harshika DubeyDirector25 Jul 20233 Years 3 MonthsCurrent
Amit Kumar JoshiDirector16 Apr 20242 Years 7 MonthsCurrent
Kavita JoshiDirector01 Nov 20179 Years 0 MonthsCurrent

Peer comparison

Ruslan Novo Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Emtris Consulting Private Limited₹38.9 Lakh (FY 2025)1.0%Pune, Maharashtra, India
Cutishine Pharmaceuticals Private Limited₹38.85 Lakh (FY 2025)115.0%Indore, Madhya Pradesh, India
Ranisati Financial Management Private Limited₹38.81 Lakh (FY 2025)-1.0%Howrah, West Bengal, India
SCM Groups Private Limited₹38.78 Lakh (FY 2025)-61.0%Tiruppur, Tamil Nadu, India
Vishwa Tradecom Pvt Ltd₹38.75 Lakh (FY 2025)67913.0%Kolkata, West Bengal, India
Ruslan Novo Pharmaceutical Private Limitedthis company₹38.74 Lakh (FY 2025)₹39,3461%3.0%Mumbai, Maharashtra, India
Akurab Health Care Private Limited₹38.73 Lakh (FY 2025)3.0%New Delhi, Delhi, India
Maxella Dreams Private Limited₹38.71 Lakh (FY 2025)35.0%New Delhi, Delhi, India
P T Infrastructures Private Limited₹38.7 Lakh (FY 2025)8.0%Delhi, India
Avichi Global Impex Private Limited₹38.62 Lakh (FY 2025)Bhopal, Madhya Pradesh, India
Byennet Pharmaceutical Private Limited₹38.62 Lakh (FY 2025)0.0%Aurangabad, Maharashtra, India

To see the full peer comparison of Ruslan Novo Pharmaceutical Private Limited, buy the company report.

Auditor

Ruslan Novo Pharmaceutical Private Limited is audited by Nam & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Nam & AssociatesFY 2023014430C

Shareholding

The shareholding of Ruslan Novo Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ruslan Novo Pharmaceutical Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Bank of India₹0.08 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Jun 2022100588883Bank of India₹7.5 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ruslan Novo Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ruslan Novo Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAICR6000L1ZIMadhya PradeshActive16 Nov 2017

To see the full GST registrations and return filing status of Ruslan Novo Pharmaceutical Private Limited, buy the company report.

Recent activity

Ruslan Novo Pharmaceutical Private Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Amit Kumar Joshi was appointed as Director on 16 Apr 2024.

AGM
Ruslan Novo Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Amit Kumar Joshi was appointed as Director.
Filing
Ruslan Novo Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Harshika Dubey ceased to be Additional Director.
Ceased
Amit Kumar Joshi ceased to be Director.
Appointed
Harshika Dubey was appointed as Director.
Charges
A charge with Bank Of India amounted to Rs. 7.50 Lakh with Charge ID 100588883 was registered on 17 Jun 2022.
Appointed
Kavita Joshi was appointed as Director.
Incorporation
01 Nov 2017
Ruslan Novo Pharmaceutical Private Limited was registered on 01 Nov 2017 with Roc Mumbai & aged 9 years 16 days as per MCA records.

Frequently asked questions

Ruslan Novo Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 November 2017 (9+ years old) and is registered under CIN U51909MH2017PTC301377.

Ruslan Novo Pharmaceutical has 3 current directors:

The latest financial statements of Ruslan Novo Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Ruslan Novo Pharmaceutical is 23AAICR6000L1ZI, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Ruslan Novo Pharmaceutical is U51909MH2017PTC301377. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ruslan Novo Pharmaceutical was incorporated on 01 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Ruslan Novo Pharmaceutical by revenue are Emtris Consulting Private Limited, Cutishine Pharmaceuticals Private Limited, Ranisati Financial Management Private Limited, SCM Groups Private Limited, Vishwa Tradecom Pvt Ltd and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).

Amit Kumar Joshi was appointed as Director on 16 Apr 2024. Harshika Dubey ceased to be Additional Director on 29 Sep 2023. Amit Kumar Joshi ceased to be Director on 07 Aug 2023. Ruslan Novo Pharmaceutical has 5 board changes on record in total.

Yes, Ruslan Novo Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Ruslan Novo Pharmaceutical can be reached through the website ruslannovo.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Ruslan Novo Pharmaceutical is at Office No. 119 1st Floor Mastermind – V Royal Palms Aarey Milk Co, Lony, Mumbai, Maharashtra, India – 400065.